Press "Enter" to skip to content

New patent for Biocryst drug ORLADEYO

0
Copyright © DrugPatentWatch. Originally published at New patent for Biocryst drug ORLADEYO

Annual Drug Patent Expirations for ORLADEYO
Annual Drug Patent Expirations for ORLADEYO

Orladeyo is a drug marketed by Biocryst and is included in one NDA. There are four patents protecting this drug.

This drug has forty patent family members in twenty-seven countries.

The generic ingredient in ORLADEYO is berotralstat hydrochloride. Additional details are available on the berotralstat hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Biocryst drug ORLADEYO
DrugPatentWatch - Make Better Decisions